Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by N00bInvesT0Ron Apr 15, 2019 5:34pm
130 Views
Post# 29630151

RE:On another note, why was earnings released on a Monday?

RE:On another note, why was earnings released on a Monday?
Daredevil1964 wrote: Knowing that you do not meet expectations, and I am sure they knew. It would of been better to release these earnings as originally set. April 11. Releasing an ER on a Monday here everybody is fresh for the week and paying attention. The markets are focused on Monday morning. If a poor ER is released on a Thursday or Friday, one has the same net effect for 2 days not possibly the whole week. Something over the weekend could distract the news cycle and a weak ER can be hidden or disguised by another piece of news. Also Aphria should of ammended their guidance to warn of an earnings short fall. Aurora did that. It gives us the choice to jump ship due to the weak ER. Aphria, in my opinion is still little league T ball team playing in the majors. This is not a bash, an earnings report warning is done all the time. Aphria needs to think more about the share holders that are retail, only 10 percent is institutional ownership. Everyone best to you all. 


Agreed 100% with you, its now a double edged sword, they rather say nothing and hope to beat expectations that analysts project with their crystal ball, I bet you they just take CC pharma 2018 performance and divide it by 4 and now add it up to the 2019 500M guidance divided by 4 unless the  500M guidance include (CC Pharma).  That's just an example of how analyst really come up wtih crystal ball numbers! At least we know that future Q costs will go down and revenues will go up
Bullboard Posts